KC Animal Health Blog

<< Return to Blog List

In the Spotlight Q2 2020 | Argenta

by Danni Hammontree | Jun 29, 2020

Argenta: From Kiwi to Kansas

What started as a small R&D company in New Zealand has grown into a global CRO/CDMO/CMO, dedicated to creating partnerships that will advance veterinary drug development from Molecule-to-Market.

The trend of mergers, acquisitions and consolidations in the animal health space have led to new opportunities in the market. Today, the top 5 animal health companies are finding themselves increasingly tasked with outsourcing innovation to eager startups and other collaborators. These hungry newcomers are motivated and inventive, but often face challenges navigating the complex veterinary drug development process.

“That’s where our expertise and capabilities fit perfectly,” said Dr. Edward McGruder, Global Head of Research, Development & Innovation at Argenta. “Whether it is an ambitious startup who needs an external problem solver or a top 5 animal health company who is looking to outsource, we can take their projects from Molecule-to-Market.”

With a presence in three different continents and close to 500 animal-loving team members, we are driven to create global partnerships that accelerate the development of innovative animal health products.

Argenta Blog Image
Research & Development

Located in the Animal Health Corridor (Lawrence, KS), Argenta’s Research & Development group can solve formulation development challenges and create, qualify and validate analytical methods. They have access to (and can connect you with) other teams within Argenta’s global organization.

Regulatory Affairs & Technical Consultancy

Regulatory Affairs encompass all steps within the drug development process and the various degrees of regulation. Our professionals guide your project from Molecule-to-Market and help direct the regulatory process, manage risk, avoid pitfalls, maintain timelines and stay on budget throughout all drug development stages.


Innovation is in our DNA. Our innovation team carries out independent research for the development of novel drug delivery systems. Examples of this are our patented controlled-release, dispersible granule, transdermal, and chewable technologies.

Clinical Studies and Data Management

Dedicated to advancing new animal health products, we help companies achieve their clinical studies on time, within budget, and with the highest quality of data. All studies are conducted in compliance with Good Clinical Practice (VICH-GCP).

Commercial Manufacturing

We have three state-of-the-art GMP manufacturing facilities. One in Fort Dodge (Iowa), one in Scotland and one in New Zealand. We produce a broad scope of successful products for our clients – from small volume companion animal products right through to larger volume livestock products.

For more information or to get in touch with Argenta, please visit our website.




Tweet @AHCorridor

News Releases

Media Coverage

The Connector